🔥🐔 BizChicken 🐔🔥

Companies Similar to biote Corp.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Lixte Biotechnology Holdings, Inc.

Lixte Biotechnology Holdings, Inc. logo
Market Cap: Lowest
Employees: Lowest

LB-100 series and LB-200 series

Lixte Biotechnology Holdings, Inc. is a drug discovery company leveraging biomarker technology to develop enzyme-targeting drugs for cancer, vascular, metabolic, hereditary, and neurodegenerative diseases.

Tags: biomarker technology, biotechnology, cancer treatment, drug discovery, enzyme targets

Symbol: LIXT

Recent Price: $2.00

Industry: Biotechnology

CEO: Mr. Bastiaan van der Baan M.Sc.

Sector: Healthcare

Employees: 3

Address: 680 East Colorado Boulevard, Pasadena, CA 91101

Phone: 631 830 7092

Last updated: 2024-12-31

PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc. logo
Market Cap: Lowest
Employees: Lowest

Cell-in-a-Box

Pharma Cyte Biotech, Inc. is a biotechnology company focused on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites. Their therapies are based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology, used for treating various cancers and diabetes.

Tags: Cell-in-a-Box, biotechnology, cancer, cannabis plant, cellular therapies, diabetes, insulin-dependent diabetes, live cell encapsulation, pancreatic cancer

Symbol: PMCB

Recent Price: $1.55

Industry: Biotechnology

CEO: Mr. Joshua N. Silverman

Sector: Healthcare

Employees: 2

Address: 3960 Howard Hughes Parkway, Las Vegas, NV 89169

Phone: 917 595 2850

Leadership

  • Joshua N. Silverman, Independent Director
  • Dr. Michael M. Abecassis, Independent Director
  • Robert Weinstein, Director
  • Wayne R. Walker, Director
  • Jonathan L. Schechter, Independent Director
  • Dr. Abecassis, Director
  • Kenneth L. Waggoner, Independent Director
  • Daniel C. Farb, Independent Director
  • Daniel C. Allen, Independent Director
  • Jack E. Stover, Independent Director

Last updated: 2024-12-31

Molecular Templates, Inc.

Molecular Templates, Inc. logo
Market Cap: Lowest
Employees: Lowest

ETB Drug Platform

Molecular Templates, Inc. is a clinical stage biopharmaceutical company focused on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company develops therapies through its proprietary biologic engineered toxin body (ETB) drug platform.

Tags: ETB platform, biologic therapeutics, biopharmaceutical, cancer treatment, clinical trials

Symbol: MTEM

Recent Price: $0.05

Industry: Biotechnology

CEO: Dr. Eric E. Poma Ph.D.

Sector: Healthcare

Employees: 62

Address: 9301 Amberglen Boulevard, Austin, TX 78729

Phone: 512 869 1555

Leadership

  • Eric Poma, Ph.D., Chief Executive Officer & Chief Scientific Officer
  • Jason Kim, President & Chief Financial Officer
  • Kristen Quigley, Chief Operating Officer
  • Grace Kim, Chief Strategy Officer & Head of Investor Relations
  • Michelle Iwamoto-Fan, Ph.D., J.D., Senior Vice President and General Counsel
  • Chris Moore, Ph.D., Senior Vice President and Head of Preclinical Development and Translational Medicine
  • Joseph Phillips, Ph.D., Senior Vice President and Head of CMC Development
  • Harold E. “Barry” Selick, Ph.D., Chairman of the Board
  • David R. Hoffmann, Director
  • Kevin M. Lalande, Founding Managing Director and Chief Investment Officer of Santé
  • Gabriela Gruia, M.D., Director
  • Corsee Sanders, Ph.D., Director

Last updated: 2024-12-31

Biora Therapeutics, Inc.

Biora Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

oral biotherapeutics

Biora Therapeutics, Inc., a biotechnology company, focuses on developing oral biotherapeutics using ingestible smart capsules for targeted delivery in the gastrointestinal tract and needle-free delivery into the intestinal mucosa.

Tags: GI diseases, biotechnology, diagnostics, inflammatory bowel diseases, oral biotherapeutics, systemic uptake

Symbol: BIOR

Recent Price: $0.22

Industry: Biotechnology

CEO: Mr. Aditya P. Mohanty M.B.A.

Sector: Healthcare

Employees: 58

Address: 4330 La Jolla Village Drive, San Diego, CA 92122

Phone: 855 293 2639

Leadership

  • Adi Mohanty, MBA, Chief Executive Officer & Board Member
  • Eric d’Esparbes, Chief Financial Officer
  • Robyn Hatton, Head of Human Resources
  • Ariella Kelman, MD, Chief Medical Officer
  • James Knight, MBA, Head of Business Development
  • Clarke Neumann, JD, General Counsel and Secretary
  • Paul Shabram, MBA, Head of Technical Operations
  • Sharat Singh, PhD, Head of Research
  • Maria (Mimi) Villanueva CPMI, PPMC, Vice President, Product Development Operations & Program Management
  • Jeffrey Alter, MBA, Board Chair
  • Jeffrey Ferrell, Board Member
  • Jill Howe, Board Member
  • Brian Kotzin, MD, Board Member
  • Lynne Powell, MBA, Board Member
  • Bruce Sands, MD, MS, Advisory Board Chair
  • Geert D’Haens, MD, PhD, Advisory Board Member
  • Brian Feagan, MD, FRCPC, Advisory Board Member
  • Séverine Vermeire, MD, PhD, Advisory Board Member
  • Satish Rao, MD, PhD, Advisory Board Chair
  • William Chey, MD, Advisory Board Member
  • Anthony Lembo, MD, Advisory Board Member
  • Mark Pimentel, MD, Advisory Board Member

Last updated: 2024-12-31

BioVie Inc.

BioVie Inc. logo
Market Cap: Lowest
Employees: Lowest

BIV201, NE3107

Bio Vie Inc., a clinical stage biotechnology company, focuses on discovering, developing, and commercializing drug therapies in the United States, with products targeting liver cirrhosis, Alzheimer's, Parkinson's, multiple myeloma, and prostate cancer.

Tags: Alzheimer's, Biotechnology, Clinical Trials, Drug Development, Liver Cirrhosis, Parkinson's, Pharmaceutical

Symbol: BIVI

Recent Price: $2.09

Industry: Biotechnology

CEO: Mr. Cuong Viet Do M.B.A.

Sector: Healthcare

Employees: 14

Address: 680 West Nye Lane, Carson City, NV 89703

Phone: 775 888 3162

Last updated: 2024-12-31

89bio, Inc.

89bio, Inc. logo
Market Cap: Medium
Employees: Low

pegozafermin

89bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for liver and cardio-metabolic diseases, primarily through its lead product candidate, pegozafermin, designed to treat nonalcoholic steatohepatitis and severe hypertriglyceridemia.

Tags: biopharmaceutical, cardio-metabolic, clinical-stage, hypertriglyceridemia, liver diseases, nonalcoholic steatohepatitis, pegozafermin

Symbol: ETNB

Recent Price: $7.87

Industry: Biotechnology

CEO: Mr. Rohan Palekar

Sector: Healthcare

Employees: 70

Address: 142 Sansome Street, San Francisco, CA 94104

Phone: 415 432 9270

Last updated: 2024-12-31

Biomerica, Inc.

Biomerica, Inc. logo
Market Cap: Lowest
Employees: Low

diagnostic and therapeutic products

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.

Tags: biomedical, diabetes, diagnostic, food intolerances, gastrointestinal, therapeutic

Symbol: BMRA

Recent Price: $0.31

Industry: Medical - Devices

CEO: Mr. Zackary S. Irani

Sector: Healthcare

Employees: 64

Address: 17571 Von Karman Avenue, Irvine, CA 92614

Phone: 949 645 2111

Last updated: 2024-12-31

Benitec Biopharma Inc.

Benitec Biopharma Inc. logo
Market Cap: Low
Employees: Lowest

BB-301 and BB-103

Benitec Biopharma Inc. is a development-stage biotechnology company specializing in DNA-directed RNA interference-based therapeutics for chronic and life-threatening conditions. Its lead products include BB-301 for oculopharyngeal muscular dystrophy and BB-103 for chronic hepatitis B virus infection.

Tags: RNA interference, biotechnology, chronic conditions, gene therapy, genetic medicines, hepatitis B, oculopharyngeal muscular dystrophy

Symbol: BNTC

Recent Price: $12.51

Industry: Biotechnology

CEO: Dr. Jerel A. Banks M.D., Ph.D.

Sector: Healthcare

Employees: 16

Address: 3940 Trust Way, Hayward, CA 94545

Phone: 510 780 0819

Leadership

  • Jerel Banks, M.D., Ph.D., Chief Executive Officer & Chairman of the Board
  • Megan Boston, Executive Director

Last updated: 2024-12-31

biote Corp.

biote Corp. logo
Market Cap: Low
Employees: Low

Biote platform

biote Corp. operates in the hormone optimization space, offering a platform for Biote-certified practitioners to manage hormone imbalances and prescribe therapies. The company sells Biote-branded supplements and pellet insertion kits.

Tags: bioidentical therapies, dietary supplements, hormone optimization, medical practice

Symbol: BTMD

Recent Price: $5.91

Industry: Medical - Care Facilities

CEO: Ms. Teresa S. Weber

Sector: Healthcare

Employees: 194

Address: 1875 West Walnut Hill Lane, Irving, TX 75038

Phone: 844-604-1246

Last updated: 2024-12-31

Coya Therapeutics, Inc.

Coya Therapeutics, Inc. logo
Market Cap: Low
Employees: Lowest

COYA 101

Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs), focusing on enhancing biologics and therapies for neurodegenerative and autoimmune diseases.

Tags: Tregs, autoimmune diseases, biotechnology, neurodegenerative diseases, therapy

Symbol: COYA

Recent Price: $5.81

Industry: Biotechnology

CEO: Dr. Howard Berman Ph.D.

Sector: Healthcare

Employees: 8

Address: 5850 San Felipe Street, Houston, TX 77057

Phone: 800-587-8170

Last updated: 2024-12-31

Forte Biosciences, Inc.

Forte Biosciences, Inc. logo
Market Cap: Lowest
Employees: Lowest

FB-102

Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company based in Dallas, Texas, developing the FB-102 program for autoimmune diseases like vitiligo and alopecia areata.

Tags: FB-102, alopecia areata, autoimmune diseases, biopharmaceutical, vitiligo

Symbol: FBRX

Recent Price: $21.14

Industry: Biotechnology

CEO: Dr. Paul A. Wagner Ph.D.

Sector: Healthcare

Employees: 11

Address: 3060 Pegasus Park Drive, Dallas, TX 75247

Phone: 310 618 6994

Last updated: 2024-12-31

Omega Therapeutics, Inc.

Omega Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Low

OMEGA Epigenomic Programming platform

Omega Therapeutics, Inc. is a development-stage biopharmaceutical company leveraging its OMEGA Epigenomic Programming platform to utilize the power of epigenetics for therapeutic interventions across various diseases.

Tags: biopharmaceutical, chronic liver diseases, corneal regeneration, epigenetics, gene control, idiopathic pulmonary fibrosis

Symbol: OMGA

Recent Price: $0.80

Industry: Biotechnology

CEO: Mr. Mahesh Karande

Sector: Healthcare

Employees: 93

Address: 20 Acorn Park Drive, Cambridge, MA 02140

Phone: 617 949 4360

Leadership

  • Mahesh Karande, President & Chief Executive Officer
  • Kaan Certel, Ph.D., Chief Business Officer
  • Jennifer Nelson, Ph.D., Senior Vice President, Research
  • Tony Mullin, Chief People Officer
  • Barbara Chan, Senior Vice President, Finance and Chief Accounting Officer
  • Lisamarie Fahy, Senior Vice President, Clinical Development Operations
  • Joe Newman, Ph.D., Senior Vice President, Early Discovery
  • Jeff Atkinson, Ph.D., Vice President, Technical Operations
  • Eva Stroynowski, Senior Vice President, Investor Relations and Corporate Affairs

Last updated: 2024-12-31

Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp. logo
Market Cap: Lowest
Employees: Lowest

INTASYL therapeutic platform

Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics using its INTASYL therapeutic platform to target tumor and immune cells by regulating genes of the immune system, focusing on products like PH-762, PH-894, and PH-804 for enhancing cancer immunotherapies in adoptive cell transfer.

Tags: ACT, BRD4, Biotechnology, Cancer, Immuno-Oncology, PD-1, TIGIT, Therapeutics

Symbol: PHIO

Recent Price: $1.90

Industry: Biotechnology

CEO: Mr. Robert J. Bitterman

Sector: Healthcare

Employees: 8

Address: 257 Simarano Drive, Marlborough, MA 01752

Phone: 508 767 3861

Last updated: 2024-12-31

Sana Biotechnology, Inc.

Sana Biotechnology, Inc. logo
Market Cap: Medium
Employees: Medium

N/A

Sana Biotechnology, Inc. focuses on utilizing engineered cells as medicines, developing cell engineering platforms for various therapeutic areas including oncology, diabetes, and genetic disorders.

Tags: biotechnology, cell engineering, genetic disorders, medicine, oncology

Symbol: SANA

Recent Price: $1.61

Industry: Biotechnology

CEO: Dr. Steven D. Harr M.D.

Sector: Healthcare

Employees: 328

Address: 188 East Blaine Street, Seattle, WA 98102

Phone: 206 701 7914

Last updated: 2024-12-31

Scopus BioPharma Inc.

Scopus BioPharma Inc. logo
Market Cap: Lowest
Employees: Lowest

Duet Platform

Scopus Bio Pharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics for serious diseases with lead programs in immuno-oncology gene therapy.

Tags: biopharmaceutical, cancer treatment, gene therapy, immuno-oncology, therapeutics

Symbol: SCPS

Recent Price: $0.00

Industry: Biotechnology

CEO: Dr. Alan D. Horsager Ph.D.

Sector: Healthcare

Employees: 13

Address: 420 Lexington Avenue, New York, NY 10170

Phone: 212 479 2513

Last updated: 2024-12-31

Soligenix, Inc.

Soligenix, Inc. logo
Market Cap: Lowest
Employees: Lowest

SGX301 (Hy Bryte), SGX942, SGX203, SGX302

Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases, operating in the Specialized Bio Therapeutics and Public Health Solutions segments.

Tags: Crohn's disease, SGX301, SGX942, biopharmaceutical, oral mucositis, psoriasis, rare diseases

Symbol: SNGX

Recent Price: $2.91

Industry: Biotechnology

CEO: Dr. Christopher J. Schaber Ph.D.

Sector: Healthcare

Employees: 13

Address: 29 Emmons Drive, Princeton, NJ 08540

Phone: 609 538 8200

Leadership

  • Christopher J. Schaber, PhD, Chairman, President and Chief Executive Officer
  • Gregg A. Lapointe, CPA, MBA, Board Director
  • Diane L. Parks, MBA, Board Director
  • Robert J. Rubin, MD, Board Director
  • Jerome Zeldis, MD, PhD, Board Director

Last updated: 2024-12-31

Bio-Techne Corporation

Bio-Techne Corporation logo
Market Cap: Highest
Employees: High

Life Science Reagents, Instruments, and Services

Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for research and clinical diagnostics globally, operating through segments like Protein Sciences and Diagnostics and Genomics.

Tags: Diagnostics, Genomics, Instruments, Life Science, Protein Sciences, Reagents

Symbol: TECH

Recent Price: $72.29

Industry: Biotechnology

CEO: Mr. Kim Kelderman

Sector: Healthcare

Employees: 3100

Address: 614 McKinley Place N.E., Minneapolis, MN 55413

Phone: 612 379 8854

Last updated: 2024-12-31

Third Harmonic Bio, Inc.

Third Harmonic Bio, Inc. logo
Market Cap: Medium
Employees: Lowest

THB001

Third Harmonic Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing medicine for allergic and inflammatory diseases, including THB001, an oral small-molecule KIT inhibitor for treating chronic urticaria and other indications.

Tags: KIT inhibitor, allergic diseases, biopharmaceutical, chronic urticaria, clinical-stage, inflammatory diseases

Symbol: THRD

Recent Price: $10.38

Industry: Biotechnology

CEO: Ms. Natalie C. Holles

Sector: Healthcare

Employees: 42

Address: 300 Technology Square, Cambridge, MA 02139

Phone: 617-915-6680

Last updated: 2024-12-31

BioLife Solutions, Inc.

BioLife Solutions, Inc. logo
Market Cap: Medium
Employees: Medium

bioproduction tools and services

Bio Life Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services essential for the cell and gene therapy industry globally. The company's offerings include biopreservation media products, automated thawing products, cloud-connected shipping containers, and storage solutions for biologics and pharmaceuticals.

Tags: biological storage, biologics, biopreservation, cell therapy, cryogenic equipment, gene therapy, pharmaceuticals, temperature-sensitive storage

Symbol: BLFS

Recent Price: $26.27

Industry: Medical - Instruments & Supplies

CEO: Mr. Roderick de Greef

Sector: Healthcare

Employees: 409

Address: 3303 Monte Villa Parkway, Bothell, WA 98021

Phone: 425 402 1400

Leadership

  • Rod de Greef, Chairman & Chief Executive Officer
  • Aby J. Mathew, Ph.D., Executive Vice President and Chief Scientific Officer
  • Karen Foster, Chief Quality and Operations Officer
  • Troy Wichterman, Chief Financial Officer
  • Todd Berard, Chief Marketing Officer
  • Garrie Richardson, Chief Revenue Officer
  • Sarah Aebersold, Chief Human Resources Officer
  • Mike Pallotta, Global VP, Hardware and Electrical Engineering
  • Brett Stucker, VP of Cybersecurity and Information Security Officer
  • Amy DuRoss,
  • Rachel Ellingson,
  • Joydeep Goswami, MBA, Ph.D.,
  • Tim Moore,
  • Joseph Schick, Chairman – Audit Committee
  • Andrew Hinson,
  • Anthony Davies, Ph.D.,
  • Colleen Delaney, M.D., M.Sc.,
  • Dayong Gao, Ph.D.,
  • Erik Woods, Ph.D., HCLD(ABB),
  • Jon Rowley, Ph.D.,
  • John McMannis, Ph.D.,
  • Jerry E. Cooley, M.D.,
  • Jason Acker, MBA, Ph.D.,
  • Lizabeth Cardwell, MT (ASCP), MBA, RAC,
  • Scott R. Burger, M.D.,
  • Shelly Heimfeld, Ph.D.,

Last updated: 2024-12-31

Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

TERN-101, TERN-201, TERN-501, TERN-601

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and obesity, incorporating products like TERN-101, TERN-201, TERN-501, and TERN-601.

Tags: NASH, biopharmaceutical, clinical trials, obesity, pharmaceutical research

Symbol: TERN

Recent Price: $7.15

Industry: Biotechnology

CEO: Ms. Amy L. Burroughs M.B.A.

Sector: Healthcare

Employees: 66

Address: 1065 East Hillsdale Boulevard, Foster City, CA 94404

Phone: 650 525 5535

Last updated: 2024-11-08